Search

everythinglearnresearchcommunity

for

Search:↓

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

Taking finasteride can partially improve oxygen levels in hospitalized male patients over 50 with COVID-19 pneumonia, but it doesn't affect other outcomes like death rate or hospital stay length.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Lower LDL-c levels predict higher COVID-19 mortality.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

A team of different healthcare experts is good for treating long-term COVID-19 issues.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.